Elos Medtech AB (publ) develops and manufactures medical devices and components for the medical technology industry. More Details
Excellent balance sheet and good value.
Share Price & News
How has Elos Medtech's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: ELOS B is not significantly more volatile than the rest of Swedish stocks over the past 3 months, typically moving +/- 5% a week.
Volatility Over Time: ELOS B's weekly volatility (5%) has been stable over the past year.
7 Day Return
SE Medical Equipment
1 Year Return
SE Medical Equipment
Return vs Industry: ELOS B exceeded the Swedish Medical Equipment industry which returned 64% over the past year.
Return vs Market: ELOS B exceeded the Swedish Market which returned 45.8% over the past year.
Long-Term Price Volatility Vs. Market
How volatile is Elos Medtech's share price compared to the market and industry in the last 5 years?
Simply Wall St News
5 days ago | Simply Wall StThe Independent Director of Elos Medtech AB (publ) (STO:ELOS B), Jeppe Magnusson, Just Sold 100% Of Their Holding
2 months ago | Simply Wall StAnnouncing: Elos Medtech (STO:ELOS B) Stock Increased An Energizing 203% In The Last Three Years
2 months ago | Simply Wall StIs Now The Time To Look At Buying Elos Medtech AB (publ) (STO:ELOS B)?
Is Elos Medtech undervalued compared to its fair value and its price relative to the market?
Undervalued compared to fair value
Share Price vs. Fair Value
Below Fair Value: ELOS B (SEK258) is trading below our estimate of fair value (SEK507.44)
Significantly Below Fair Value: ELOS B is trading below fair value by more than 20%.
Price To Earnings Ratio
PE vs Industry: ELOS B is good value based on its PE Ratio (33.5x) compared to the Swedish Medical Equipment industry average (42x).
PE vs Market: ELOS B is poor value based on its PE Ratio (33.5x) compared to the Swedish market (23x).
Price to Earnings Growth Ratio
PEG Ratio: ELOS B is poor value based on its PEG Ratio (2.3x)
Price to Book Ratio
PB vs Industry: ELOS B is good value based on its PB Ratio (3.6x) compared to the SE Medical Equipment industry average (5.8x).
How is Elos Medtech forecast to perform in the next 1 to 3 years based on estimates from 1 analyst?
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: ELOS B's forecast earnings growth (14.4% per year) is above the savings rate (0.3%).
Earnings vs Market: ELOS B's earnings (14.4% per year) are forecast to grow faster than the Swedish market (4.3% per year).
High Growth Earnings: ELOS B's earnings are forecast to grow, but not significantly.
Revenue vs Market: ELOS B's revenue (13.3% per year) is forecast to grow faster than the Swedish market (2.9% per year).
High Growth Revenue: ELOS B's revenue (13.3% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: ELOS B's Return on Equity is forecast to be low in 3 years time (12.9%).
How has Elos Medtech performed over the past 5 years?
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: ELOS B has a large one-off loss of SEK40.0M impacting its June 30 2021 financial results.
Growing Profit Margin: ELOS B's current net profit margins (9.5%) are higher than last year (4.9%).
Past Earnings Growth Analysis
Earnings Trend: ELOS B's earnings have grown by 16.6% per year over the past 5 years.
Accelerating Growth: ELOS B's earnings growth over the past year (115%) exceeds its 5-year average (16.6% per year).
Earnings vs Industry: ELOS B earnings growth over the past year (115%) exceeded the Medical Equipment industry 36.9%.
Return on Equity
High ROE: ELOS B's Return on Equity (10.7%) is considered low.
How is Elos Medtech's financial position?
Financial Position Analysis
Short Term Liabilities: ELOS B's short term assets (SEK372.4M) exceed its short term liabilities (SEK178.6M).
Long Term Liabilities: ELOS B's short term assets (SEK372.4M) exceed its long term liabilities (SEK316.6M).
Debt to Equity History and Analysis
Debt Level: ELOS B's debt to equity ratio (42.1%) is considered high.
Reducing Debt: ELOS B's debt to equity ratio has reduced from 96% to 42.1% over the past 5 years.
Debt Coverage: ELOS B's debt is well covered by operating cash flow (51.1%).
Interest Coverage: ELOS B's interest payments on its debt are well covered by EBIT (23.8x coverage).
What is Elos Medtech current dividend yield, its reliability and sustainability?
Current Dividend Yield
Dividend Yield vs Market
Notable Dividend: ELOS B's dividend (0.58%) isn’t notable compared to the bottom 25% of dividend payers in the Swedish market (0.92%).
High Dividend: ELOS B's dividend (0.58%) is low compared to the top 25% of dividend payers in the Swedish market (3.4%).
Stability and Growth of Payments
Stable Dividend: ELOS B's dividend payments have been volatile in the past 10 years.
Growing Dividend: ELOS B's dividend payments have not increased over the past 10 years.
Current Payout to Shareholders
Dividend Coverage: With its low payout ratio (19.5%), ELOS B's dividend payments are well covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: ELOS B's dividends in 3 years are forecast to be thoroughly covered by earnings (13.9% payout ratio).
How experienced are the management team and are they aligned to shareholders interests?
Average management tenure
Jan Wahlström (54 yo)
Mr. Jan Wahlström has been the Chief Executive Officer and President of Elos Medtech AB since July 1, 2016. Mr. Wahlström joined Elos Medtech from his role as President of Larodan AB. Mr. Wahlström served ...
Experienced Management: ELOS B's management team is not considered experienced ( 1.4 years average tenure), which suggests a new team.
Experienced Board: ELOS B's board of directors are considered experienced (4.6 years average tenure).
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: ELOS B insiders have only sold shares in the past 3 months.
Recent Insider Transactions
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Elos Medtech AB (publ)'s company bio, employee growth, exchange listings and data sources
- Name: Elos Medtech AB (publ)
- Ticker: ELOS B
- Exchange: OM
- Founded: 1923
- Industry: Health Care Equipment
- Sector: Healthcare
- Market Cap: kr2.082b
- Shares outstanding: 8.07m
- Website: https://www.elosmedtech.com
Number of Employees
- Elos Medtech AB (publ)
- Torsgatan 5B
- Västra Götaland County
- 411 04
Elos Medtech AB (publ) develops and manufactures medical devices and components for the medical technology industry. The company operates in three segments: Dental, Orthopedics, and Life Science. The Denta...
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2021/08/04 21:38|
|End of Day Share Price||2021/08/04 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.